Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions
Healthy
Interventions
DRUG

Perindopril 4 mg tablets of PT Dexa Medica

Test product was given as a single dose, under the procedure as described in the Section: Detailed description of the study.

DRUG

Perindopril 4 mg tablets of Servier

Reference product was given as a single dose, under the procedure as described in the Section: Detailed description of the study.

Trial Locations (1)

12430

PT Equilab International, Jakarta

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Dexa Medica Group

INDUSTRY

NCT01682577 - Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition | Biotech Hunter | Biotech Hunter